Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Oct 7 (Reuters) - Genor Biopharma Holdings Ltd
6998.HK :
* ON 13 SEPT CO ENTERED INTO MERGER AGREEMENT
* CO, EDDING GROUP COMPANY AND UNIT ENTERED INTO MERGER
AGREEMENT
* CO WILL ACQUIRE EDDING GROUP COMPANY BY WAY OF MERGER
* CONSIDERATION OF PROPOSED MERGER IS TO BE WHOLLY SETTLED
BY WAY
OF ISSUING CONSIDERATION SHARES
* UNIT GENEDD WILL BE MERGED WITH AND INTO EDDING
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman